|
1
|
(HPO:0001871)
|
Abnormality of blood and blood-forming tissues |
|
|
|
|
37 / 7739
|
|
2
|
(HPO:0001939)
|
Abnormality of metabolism/homeostasis |
|
|
|
|
328 / 7739
|
|
3
|
(OMIM)
|
Myelosuppression develops on standard doses of thiopurine drugs |
|
|
|
|
1 / 7739
|
|
4
|
(OMIM)
|
Hematopoietic toxicity develops on standard doses of thiopurine drugs |
|
|
|
|
1 / 7739
|
|
5
|
(OMIM)
|
Decreased activity of thiopurine S-methyltransferase |
|
|
|
|
1 / 7739
|
|
6
|
(OMIM)
|
Decreased metabolism of thiopurine drugs |
|
|
|
|
1 / 7739
|
|
7
|
(OMIM)
|
Increased toxic thioguanine nucleotides (TGNs) on standard doses of thiopurine drugs |
|
|
|
|
1 / 7739
|
|
8
|
(HPO:0000007)
|
Autosomal recessive inheritance |
|
|
|
|
2538 / 7739
|